Impetigo:グローバル臨床試験レビューH1, 2013...市場調査レポートについてご紹介

【英文タイトル】Impetigo Global Clinical Trials Review, H1, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Impetigo 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Impetigo 23
Subjects Recruited Over a Period of Time 24
Prominent Sponsors 25
Top Companies Participating in Impetigo Therapeutics Clinical Trials 27
Prominent Drug Comparison 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
GlaxoSmithKline plc 30
Clinical Trial Overview of GlaxoSmithKline plc 30
Lytix Biopharma AS 31
Clinical Trial Overview of Lytix Biopharma AS 31
LEO Pharma A/S 32
Clinical Trial Overview of LEO Pharma A/S 32
NovaBay Pharmaceuticals, Inc. 33
Clinical Trial Overview of NovaBay Pharmaceuticals, Inc. 33
Ferrer Internacional S.A. 34
Clinical Trial Overview of Ferrer Internacional S.A. 34
Foamix Ltd. 35
Clinical Trial Overview of Foamix Ltd. 35
Interdos Pharma bv 36
Clinical Trial Overview of Interdos Pharma bv 36
Ambria Dermatology AB (Inactive) 37
Clinical Trial Overview of Ambria Dermatology AB (Inactive) 37
InfectoPharm Arzneimittel und Consilium GmbH 38
Clinical Trial Overview of InfectoPharm Arzneimittel und Consilium GmbH 38
GlaxoSmithKline Inc. 39
Clinical Trial Overview of GlaxoSmithKline Inc. 39
Galderma S.A. 40
Clinical Trial Overview of Galderma S.A. 40
Stiefel Laboratories, Inc. 41
Clinical Trial Overview of Stiefel Laboratories, Inc. 41
Clinical Trial Overview of Top Universities / Institutes / Hospitals 42
Menzies School of Health Research 42
Clinical Trial Overview of Menzies School of Health Research 42
Royal North Shore Hospital 43
Clinical Trial Overview of Royal North Shore Hospital 43
The University of Texas Health Science Center at Houston 44
Clinical Trial Overview of The University of Texas Health Science Center at Houston 44
Five Key Clinical Profiles 45
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 83


【レポート販売概要】

■ タイトル:Impetigo:グローバル臨床試験レビューH1, 2013
■ 英文:Impetigo Global Clinical Trials Review, H1, 2013
■ 発行日:2013年3月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160650
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。